Denmark· DK-28120211593
MIBG (I123)
A iobenguane (123i) product, registered in Denmark by Curium Netherlands B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Iobenguane (123i) is registered in 9 of 19 countries.
Countries holding a registration under ATC V09IX01 (iobenguane (123i)), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Iobenguane (123i) · ATC V09IX01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Manufacturer
- Curium Netherlands B.V.
- Country
- Denmark (DK)
- ATC code
- V09IX01
- ATC class
- Iobenguane (123I)
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28120211593
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
241 interactions on record for iobenguane (123i).
Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iobenguane (123i) · interactions on record
241 records
- 143 severe
- 98 moderate
Most severe, free to view
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- MazindolA08AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V09IX01
Iobenguane (123i), as other registers publish it.
- CanadaADREVIEWGE HEALTHCARE CANADA INC
- BelgiumAdreview 74 MBq/mlGE Healthcare
- SwitzerlandAdreView Iobenguane (I-123)
- NetherlandsAdreView, Iobenguane (123I) Injection, oplossing voor injectie 74 MBq/mlGE Healthcare B.V.
- SwitzerlandAdreView, Iobenguane (I-123) Injectionmedeo AG
- SwitzerlandAdreView, Iobenguane (I-123) Injectionmedeo AG
- SwitzerlandAdreView, Iobenguane (I-123) Injectionmedeo AG
- SwitzerlandAdreView, Iobenguane (I-123) Injectionmedeo AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb5a3fc7-1dfd-44d9-9819-05932615bc6f GET /v1/drugs/eb5a3fc7-1dfd-44d9-9819-05932615bc6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske",
"source": "dkma",
"strength": "10129",
"auth_role": "DKMA",
"dk_drugid": "28120211593",
"substance": null,
"auth_procedure": "National",
"in_medicinpriser": false,
"registration_date_serial": "34729"
}See everything about iobenguane (123i).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.